TARDBP and fragile X-associated tremor/ataxia syndrome: We next determined whether nsP3-WT expression could enhance survival in two established disease models: a TDP43 overexpression ALS/FTD model (TDP43-mApple), and a neuronal model of FXTAS ((CGG)100-EGFP) (57,58).